
OpenNano, Journal Year: 2024, Volume and Issue: unknown, P. 100224 - 100224
Published: Dec. 1, 2024
Language: Английский
OpenNano, Journal Year: 2024, Volume and Issue: unknown, P. 100224 - 100224
Published: Dec. 1, 2024
Language: Английский
International Journal of Biological Macromolecules, Journal Year: 2025, Volume and Issue: unknown, P. 139709 - 139709
Published: Jan. 1, 2025
Language: Английский
Citations
1Biomaterials Advances, Journal Year: 2025, Volume and Issue: 171, P. 214235 - 214235
Published: Feb. 15, 2025
Language: Английский
Citations
0Journal of Functional Biomaterials, Journal Year: 2024, Volume and Issue: 15(8), P. 206 - 206
Published: July 25, 2024
Bismuth lipophilic nanoparticles (BisBAL NPs) and cetylpyridinium chloride (CPC) are antineoplastic antimicrobial in vitro. As a next pre-clinical step, clinically viable dosage form for vaginal application was developed. Compendial pharmacopeial tests (mass uniformity, disintegration, compressive mechanics) inductively coupled plasma optical emission spectroscopy were conducted on in-house developed glycerinated gelatin (60:15
Language: Английский
Citations
2Journal of drug targeting, Journal Year: 2024, Volume and Issue: unknown, P. 1 - 14
Published: June 4, 2024
The use of reactive oxygen species (ROS) to target cancer cells has become a hot topic in tumor therapy.
Language: Английский
Citations
0Oral Oncology Reports, Journal Year: 2024, Volume and Issue: 11, P. 100635 - 100635
Published: Aug. 25, 2024
This comprehensive review explores the potential of nanotherapy in treatment blood cancers, specifically leukemia, lymphoma, and myeloma, oral cavity. Nanoparticles (NPs) made from organic inorganic materials have shown promise delivering therapeutic substances to cancer cells, enhancing their pharmacological efficacy, reducing systemic toxicity. Different types nanoparticles, such as liposomes, extracellular vehicles, polymeric been studied for effectiveness targeting cells. Nanotherapy has also investigated overcoming drug resistance, stem bypassing efflux pumps, gene silencing. Clinical trials research findings demonstrated improving outcomes patients with acute myeloid chronic lymphocytic Hodgkin non-Hodgkin multiple myeloma. However, challenges exist addressing heterogeneity cancers cavity, navigating tumor microenvironment, modulating immune evasion. Future directions include individualized plans, multifunctional combination therapies, improved nanoparticle design. The translation these breakthroughs into clinical practice requires collaboration among researchers, physicians, industry stakeholders. Overall, holds more effective less invasive treatments
Language: Английский
Citations
0RSC Advances, Journal Year: 2024, Volume and Issue: 14(48), P. 36115 - 36131
Published: Jan. 1, 2024
Gold nanoparticles (AuNPs) exhibit different physical properties compared to small molecules, bulk materials and other nanoparticles. Their synthesis using plant extracts, particularly polyflavonoids as phytoreductants, for the conversion of Au(iii) into Au(0) has been reported. In this study, AuNPs were synthesized with sterols pure compounds derived from marine sponges gold(iii) chloride trihydrate. Extracts, hexane (JDH) ethyl acetate (JDE), (JC-2) jaspamide obtained
Language: Английский
Citations
0OpenNano, Journal Year: 2024, Volume and Issue: unknown, P. 100224 - 100224
Published: Dec. 1, 2024
Language: Английский
Citations
0